Leadership, Planning and Evaluation

领导、规划和评估

• 批准号: 10627035
• 负责人: ROBERT S. MANNEL
• 金额: $ 18.86万
• 依托单位: UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-05-01 至 2028-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10627035
• 关键词: Address; Appointment; Basic Science; Cancer Center; Cancer Center Support Grant; Catchment Area; Clinical; Clinical Cancer Center; Clinical Research; Collaborations; Communication; Communities; Community Outreach; Component of the Center for Cancer Research; Data; Decision Making; Development; Diabetes Mellitus; Doctor of Philosophy; Education; Effectiveness; Ensure; Evaluation; Evaluation Research; Faculty; Fostering; Funding; Geroscience; Goals; Leadership; Malignant Neoplasms; Mentorship; Minority Groups; Minority Women; Mission; NCI Center for Cancer Research; Oklahoma; Outcome; Persons; Play; Policies; Positioning Attribute; Process; Productivity; Publications; Reporting; Research; Research Activity; Resource Allocation; Resource Sharing; Role; Science; Strategic Planning; Students; Training; Translational Research; Translations; Underrepresented Minority; Update; cancer research center director; cancer risk; career; community engagement; community setting; design; equity, diversity, and inclusion; experience; improved outcome; meetings; operation; programs

LEADERSHIP, PLANNING AND EVALUATION: ABSTRACT The Stephenson Cancer Center (SCC) conducts formal planning and evaluation activities, under the oversight of the SCC director and senior leadership team, to advance its mission of eliminating cancer in Oklahoma (SCC catchment area) and beyond. Planning and evaluation are critically important for a matrix cancer center like the SCC to ensure optimal coordination, integration, and effectiveness of SCC activities and resource allocation. The following core strategic priorities inform the goals, tactics, and metrics for all SCC research components: 1) enhancing breadth, depth, and impact of cancer-focused research; 2) fostering the translation of discoveries into the clinical or community setting; 3) designing and conducting hypothesis-driven trials to improve outcomes for people with or at risk for cancer; 4) promoting intra- and inter-programmatic collaboration and transdisciplinary team science; 5) enhancing COE to address priority cancers and cancer problems prevalent in the SCC catchment area; 6) increasing training and mentorship opportunities for students and faculty; and 7) enhancing the presence of underrepresented minority persons and women among SCC leadership and membership, and in pipeline programs. For oversight, planning, and evaluation of research activities, SCC Director Robert Mannel, MD has assembled an experienced senior leadership team of associate directors (ADs) who oversee the following functions: basic research (Danny Dhanasekaran, PhD); translational research (Priyabrata Mukherjee, PhD); clinical research (Kathleen Moore, MD); community outreach and engagement (Mark Doescher, MD); education, training, and career enhancement (Rajagopal Ramesh, PhD); diversity, equity, and inclusion (Joan Walker, MD); and research administration (Wade Williams, PhD). Since Mannel’s appointment as SCC director in 2006, strategic planning and evaluation has played a central role in the development of the SCC. The standing Research Leadership Committee (RLC) and Research Steering Committee (RSC), which are comprised of leaders for all research components at the SCC, provide regular forums for planning and evaluating progress. In addition, research leadership is well represented in SCC clinical planning and evaluation. External input from scientific and community advisory boards augment these planning and evaluation activities. New strategic initiatives emerging from planning discussions during the reporting period include: research program realignment (2018); strategic partnerships with the Oklahoma Center for Geroscience (2018) and Harold Hamm Diabetes Center (2019); new initiatives to enhance SCC research focused on catchment area priority cancers and prevalent cancer problems (2019); increased engagement with OU Norman to foster cancer-focused research and collaborations (2020); establishing a new AD position for diversity, equity, and inclusion, and broad planning for how to enhance DEI among SCC leadership and membership, and in pipeline education programs (2021).

领导力、规划和评估：摘要 斯蒂芬森癌症中心(SCC)在监督下进行正式的规划和评估活动 SCC主任和高级领导团队的支持，以推进其在俄克拉何马州消灭癌症的使命 (SCC集水区)和更远的地方。对于基质癌症中心来说，规划和评估至关重要 如SCC，以确保SCC活动和资源的最佳协调、集成和有效性 分配。以下核心战略优先事项为所有SCC研究的目标、策略和指标提供了参考 组成部分：1)加强癌症研究的广度、深度和影响；2)促进翻译 临床或社区环境中的发现；3)设计和进行假设驱动的试验，以 改善癌症患者或癌症高危人群的预后；4)促进方案内和方案间的合作 和跨学科团队科学；5)增强COE，以解决优先癌症和癌症问题 在SCC集水区普遍存在；6)增加学生和 7)加强SCC中代表不足的少数群体和妇女的存在 领导力和成员资格，以及正在筹划的项目。用于监督、规划和评估研究 活动，SCC总监Robert Mannel医学博士组建了一支经验丰富的高级领导团队 副主任(ADS)，负责监督以下职能：基础研究(丹尼·达纳塞卡兰博士)； 翻译研究(Priyabrata Mukherjee，博士)；临床研究(凯瑟琳·摩尔，医学博士)；社区 外展和参与(Mark Doescher，医学博士)；教育、培训和职业发展(Rajagopal 拉梅什，博士)；多样性、公平和包容性(琼·沃克，医学博士)；以及研究管理(韦德 威廉姆斯博士)。 自2006年Mannel被任命为SCC主管以来，战略规划和评估一直发挥着核心作用 在SCC发展中的作用。常设研究领导委员会(RLC)和研究 由SCC所有研究部门的领导组成的指导委员会(RSC)提供 定期举办规划和评估进展情况的论坛。此外，研究领导力在以下方面得到了很好的体现 鳞状细胞癌临床计划和评估。来自科学和社区咨询委员会的外部投入增加了 这些规划和评估活动。从规划讨论中涌现的新战略举措 本报告所述期间包括：研究方案调整(2018年)；与俄克拉荷马州大学的战略伙伴关系 老年科学中心(2018)和哈罗德·哈姆糖尿病中心(2019)；加强SCC的新举措 重点研究集水区优先癌症和流行癌症问题(2019年)；增加 与俄亥俄州立大学诺曼分校合作，促进癌症研究和合作(2020)；建立一个新的 多样性、公平性和包容性的广告定位，以及如何在SCC中提高DEI的广泛规划 领导力和成员资格，以及正在筹备的教育方案(2021年)。